See down below.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2017-004898-14-SE

Enrollment

Registered

2018-02-13

Start date

2018-04-03

Completion date

Unknown

Last updated

2025-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Please see below

Interventions

Trade Name: Magnesium Sulfate 50%w/v Solution for Injection Pharmaceutical Form: Solution for injection INN or Proposed INN: MAGNESIUM SULFATE HEPTAHYDRATE CAS Number: 10034-99-8 Other descriptive nam

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Please see below Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 40 F.1.3 Elderly (>=65 years) no F.1.3.1 Number of subjects for this age range

Exclusion criteria

Exclusion criteria: Please see below

Design outcomes

Primary

Measure	Time frame
Main Objective: Please see below;Secondary Objective: Please see below;Primary end point(s): Please see below;Timepoint(s) of evaluation of this end point: Please see below	—

Secondary

Measure	Time frame
Secondary end point(s): Please see below;Timepoint(s) of evaluation of this end point: Please see below	—

Countries

Sweden

Contacts

Public ContactResearch Support Office

Gothia Forum

gothia.forum@vgregion.se

Outcome results

None listed

Source: EU CTR (via WHO ICTRP) · Data processed: Feb 4, 2026